Continuous-Infusion Topotecan and Erlotinib: A Study in Topotecan-Pretreated Ovarian Cancer Assessing Shed Collagen Epitopes as a Marker of Invasiveness

Por Warner, Eiran, Liebes, Leonard, Levinson, Benjamin, Downey, Andrea, Tiersten, Amy, Muggia, Franco
Publicado em 2014

Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer

Por Fasano, Julie, Hershman, Dawn, Novik, Yelena, Levinson, Benjamin, Blozie, Kim, Tiersten, Amy D.
Publicado em 2010

Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Por McFarland, Daniel C., Naikan, Jessica, Rozenblit, Mariya, Mandeli, John, Bleiweiss, Ira, Tiersten, Amy
Publicado no J Oncol (2016)

Early Childhood Adversity and Its Associations with Anxiety, Depression, and Distress in Women with Breast Cancer

Por McFarland, Daniel C, Andreotti, Charissa, Harris, Kirk, Mandeli, John, Tiersten, Amy, Holland, Jimmie
Publicado no Psychosomatics (2015)

A Unique Presentation of Occult Primary Breast Cancer with a Review of the Literature

Por Ahmed, Inaya, Dharmarajan, Kavita, Tiersten, Amy, Bleiweiss, Ira, Schmidt, Hank, Green, Sheryl, Bakst, Richard L.
Publicado no Case Rep Oncol Med (2015)

Phase II Evaluation of Neoadjuvant Chemotherapy and Debulking Followed by Intraperitoneal Chemotherapy in Women with Stage III and IV Epithelial Ovarian, Fallopian Tube or Primary...

Por Tiersten, Amy D., Liu, P.Y., Smith, Harriet O., Wilczynski, Sharon P., Robinson, William R., Markman, Maurie, Alberts, David S.
Publicado em 2009

Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraper...

Por Tiersten, Amy D., Moon, James, Smith, Harriet O., Wilczynski, Sharon P., Robinson, 3rd, William R., Markman, Maurie, Alberts, David S.
Publicado em 2010

A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined with Paclitaxel and Pegfilgrastim: A Feasibility Study in Patients with Untreated Stage III and IV Ovarian, Tubal or P...

Por Tiersten, Amy D., Sill, Michael W., Knight, Danielle, Muggia, Franco, Garcia, Agustin A., Swensen, Ron, Warshal, David P., Mannel, Robert S., Fracasso, Paula M.
Publicado em 2010

A Phase II Study of Oxaliplatin Combined with Continuous Infusion Topotecan for Patients with Previously Treated Ovarian Cancer

Por Stein, Stacey M., Tiersten, Amy, Hochster, Howard S., Blank, Stephanie V., Pothuri, Bhavana, Curtin, John, Shapira, Ilan, Levinson, Benjamin, Ivy, Percy, Joseph, Benson, Guddati, Achuta K., Muggia, Franco
Publicado em 2013

SOUTHWEST ONCOLOGY GROUP TRIAL S9912: INTRAPERITONEAL CISPLATIN AND PACLITAXEL PLUS INTRAVENOUS PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN AS PRIMARY CHEMOTHERAPY OF SMALL-VOLU...

Por Smith, Harriet O., Moon, James, Wilczynski, Sharon P., Tiersten, Amy D., Hannigan, Edward V., Robinson, William R., Rivkin, Saul E., Anderson, Garnet L., Liu, P.Y., Markman, Maurie
Publicado em 2009

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer

Por Adams, Sylvia, Kozhaya, Lina, Martiniuk, Frank, Meng, Tze-Chiang, Chiriboga, Luis, Liebes, Leonard, Hochman, Tsivia, Shuman, Nicholas, Axelrod, Deborah, Speyer, James, Novik, Yelena, Tiersten, Amy, Goldberg, Judith D., Formenti, Silvia, Bhardwaj, Nina, Unutmaz, Derya, Demaria, Sandra
Publicado em 2012

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer

Por Singh, Jasmeet Chadha, Novik, Yelena, Stein, Stacey, Volm, Matthew, Meyers, Marlene, Smith, Julia, Omene, Coral, Speyer, James, Schneider, Robert, Jhaveri, Komal, Formenti, Silvia, Kyriakou, Victoria, Joseph, Benson, Goldberg, Judith D, Li, Xiaochun, Adams, Sylvia, Tiersten, Amy
Publicado em 2014